Exploring the binding interactions of structurally diverse dichalcogenoimidodiphosphinate ligands with α-amylase: Spectroscopic approach coupled with molecular docking

dc.contributor.authorDairo, Oluropo
dc.date.accessioned2022-04-29T16:47:15Z
dc.date.available2022-04-29T16:47:15Z
dc.date.issued2020
dc.description.abstractPostprandial hyperglycemia has orchestrated untimely death among diabetic patients over the decades and regulation of α-amylase activity is now becoming a promising management option for type 2 diabetes. The present study investigated the binding interactions of three structurally diverse dichalcogenoimidodiphosphinate ligands with α-amylase to ascertain the affinity of the ligands for α-amylase using spectroscopic and molecular docking methods. The ligands were characterized using 1H and 31P NMR spectroscopy and CHN analysis. Dis- elenoimidodiphosphinate ligand (DY300), dithioimidodiphosphinate ligand (DY301), and thio- selenoimidodiphosphinate ligand (DY302) quenched the intrinsic fluorescence intensity of α-amylase via a static quenching mechanism with bimolecular quenching constant (Kq) values in the order of x1011 M-1s-1, indicating formation of enzyme-ligand complexes. A binding stoichiometry of n≈1 was observed for α-amylase, with high binding constants (Ka). α-Amylase inhibition was as follow: Acarbose>DY301>DY300>DY302. Values of thermodynamic parameters obtained at temperatures investigated (298, 304 and 310 K) revealed spontaneous complex formation (ΔG<0) between the ligands and α-amylase; the main driving forces were hydrophobic in- teractions (with DY300, DY301, except DY302). UV–visible spectroscopy and Fo ̈rster resonance energy transfer (FRET) affirmed change in enzyme conformation and binding occurrence. Molecular docking revealed ligands interaction with α-amylase via some key catalytic site amino acid residues (Asp197, Glu233 and Asp300). DY301 perhaps showed highest α-amylase inhibition (IC50, 268.11 ± 0.74 μM) due to its moderately high affinity and composition of two sulphide bonds unlike the others. This study might provide theoretical basis for development of novel α-amylase inhibitors from dichalcogenoimidodiphosphinate ligands for management of postprandial hyperglycemia.en_US
dc.description.sponsorshipFinancial support was provided by Elsevier Foundation, with grant number: BBREPAEAx0nHYATS_BG.en_US
dc.identifier.citationAvwioroko, O.J., Oyetunde, T.T., Atanu, F.O., Otuechere, C.A., Anigboro, A.A., Dairo, O.F., Ejoh, A.S., Ajibade, S.O. and Omorogie, M.O. (2020) Exploring the binding interactions of structurally diverse dichalcogenoimidodiphosphinate ligands with α-amylase: Spectroscopic approach coupled with molecular docking, Biochemistry and Biophysics Reports, 24: 100837.en_US
dc.identifier.urihttp://dspace.run.edu.ng:8080/jspui/handle/123456789/2553
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subjectα-Amylase inhibitionen_US
dc.subjectLigand-protein bindingen_US
dc.subjectSpectroscopyen_US
dc.subjectHyperglycemiaen_US
dc.subjectAnti-diabetic agentsen_US
dc.titleExploring the binding interactions of structurally diverse dichalcogenoimidodiphosphinate ligands with α-amylase: Spectroscopic approach coupled with molecular dockingen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Paper 10.pdf
Size:
2.64 MB
Format:
Adobe Portable Document Format
Description:
Avwiorokoetal2020
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: